NASDAQ NMS - GLOBAL MARKET · IMRX
-2.26% · -$0.1200 · Vol 400.6K
Market closed · last close 4:00 PM ET · price as of 16:00:09 ET
Immuneering Corp

Immuneering Corp

Biotechnology
$5.18
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
IMRX
Immuneering Corp
Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is IMRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading IMRX catalysts
About Immuneering Corp
PHARMACEUTICAL PREPARATIONS
Listed since
2021
Employees
57
Country
US

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$5.31
Day high
$5.35
Day low
$5.13
Previous close
$5.30
52W high
$9.26
-44.06% from high
52W low
$3.92
24% of range
Market cap
$342.9M
EPS
$-1.2800
Beta
0.76
Shares out
64.7M
Volume
400.6K
0.58× rel vol
Avg volume
696.3K
VWAP
$5.23
Price history computed in-house
1W
+2.98%
1M
+19.91%
3M
-2.91%
1Y
-12.94%
YTD
-21.28%
SMA 50 $4.73 · above
SMA 200 $5.33 · below
52W position 24%

IMRX overview

Veridion Score
65
Registered · 2026-08-24
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around IMRX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading IMRX Form 4 filings
Public disclosures

Congress activity in IMRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for IMRX in the cached public ledger.

Federal contracts

IMRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for IMRX in this window.
Lobbying spend

IMRX lobbying filings, year to date.

Registered lobbying filings matched to Immuneering Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for IMRX in this window.
Loading news for IMRX
Analyst ratings
Sovereign unlock shows live analyst consensus for IMRX.
Options
Sovereign unlock shows live options positioning for IMRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.